News
IRIX
2.640
-1.86%
-0.050
Weekly Report: what happened at IRIX last week (0219-0223)?
Weekly Report · 6d ago
Zacks Industry Outlook Highlights MicroVision, Cutera and IRIDEX
NASDAQ · 02/22 08:43
3 Laser Systems Stocks to Watch in a Challenging Industry
NASDAQ · 02/21 14:20
Weekly Report: what happened at IRIX last week (0212-0216)?
Weekly Report · 02/19 11:35
IPG Photonics (IPGP) Q4 Earnings Miss Estimates
NASDAQ · 02/13 14:10
Weekly Report: what happened at IRIX last week (0205-0209)?
Weekly Report · 02/12 11:24
Iridex receives European patent on micropulse technology
Iridex receives European patent on micropulse technology for laser systems in ophthalmology and related fields. Iridex Corporation (NASDAQ:IRIX) also receives patent on laser system with short Pulse Characteristics and its methods of use. The company is a supplier of laser systems to laser manufacturers.
Seeking Alpha · 02/06 13:54
Iridex Corporation Receives European Patent On MicroPulse Technology EP 3009093, Entitled "Laser System With Short Pulse Characteristics And Its Methods Of Use"
Iridex Corporation announced the grant of the European Patent EP 3009093 for a laser system that enhances safe and effective laser treatments in ophthalmology. Iridex is the exclusive provider of MicroPulse devices that utilize the patented technology. The technology is designed to minimize the risk of retinal damage and vision loss.
Benzinga · 02/06 13:03
Weekly Report: what happened at IRIX last week (0129-0202)?
Weekly Report · 02/05 11:33
Weekly Report: what happened at IRIX last week (0122-0126)?
Weekly Report · 01/29 11:21
Weekly Report: what happened at IRIX last week (0115-0119)?
Weekly Report · 01/22 11:25
Weekly Report: what happened at IRIX last week (0108-0112)?
Weekly Report · 01/15 11:21
Weekly Report: what happened at IRIX last week (0101-0105)?
Weekly Report · 01/08 11:25
Weekly Report: what happened at IRIX last week (1225-1229)?
Weekly Report · 01/01 11:20
Iridex Says All Five Medicare Administrative Contractors Retired Their Local Coverage Determinations That Were Scheduled To Take Effect On January 29, 2024
All five Medicare Administrative Contractors retired their local coverage determinations that were scheduled to take effect on January 29, 2024. Iridex applauds the decision to retain reimbursement and full access for Medicare patients to glaucoma treatments. The company is a worldwide leader in laser-based medical systems.
Benzinga · 12/28/2023 23:17
Iridex Reports Its Successful Advocacy For Revision Of Recently Issued Medicare Local Coverage Determinations For Cyclophotocoagulation
Benzinga · 12/28/2023 23:04
Weekly Report: what happened at IRIX last week (1218-1222)?
Weekly Report · 12/25/2023 11:32
Weekly Report: what happened at IRIX last week (1211-1215)?
Weekly Report · 12/18/2023 11:38
Weekly Report: what happened at IRIX last week (1204-1208)?
Weekly Report · 12/11/2023 11:33
Weekly Report: what happened at IRIX last week (1127-1201)?
Weekly Report · 12/04/2023 11:32
More
Webull provides a variety of real-time IRIX stock news. You can receive the latest news about Iridex through multiple platforms. This information may help you make smarter investment decisions.
About IRIX
IRIDEX Corporation is an ophthalmic medical technology company, which is focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. The Company’s laser consoles products consist of Glaucoma, which includes Cyclo G6 laser and delivery devices used for the treatment of glaucoma; Medical Retina product line, which includes IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases, and its PASCAL Synthesis Photocoagulator for the treatment of retinal diseases; Surgical Retina, which includes OcuLight TX, OcuLight SL and OcuLight SLx laser photocoagulation systems. The Company’s laser probes products consist of Glaucoma, which include MicroPulse P3 Probe, G-Probe and G-Probe Illuminate, and Surgical Retina probes, which include EndoProbe family of products used in vitrectomy procedures.